Alexza Pharmaceuticals Inc. Comprehensive Income
Alexza Pharmaceuticals Inc. reported Comprehensive Income of -$3.36 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2016-05-13
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-03-31 was -$3.36M.
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2015-12-31 was -$3.02M.
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2015-09-30 was -$5.44M.
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2015-03-31 was -$402.00K.
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was -$21.31M.
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was -$36.74M.
- Alexza Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was -$39.61M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2016-03-31 | -$3.36M 10-Q · filed 2016-05-13 | -$6.38M derived: sum of 2 quarters · filed 2016-05-13 | -$11.82M derived: sum of 3 quarters · filed 2016-05-13 | |
| 2015-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$8.46M derived: sum of 2 quarters · filed 2016-03-28 | -$21.31M 10-K · filed 2016-03-28 | |
| 2015-09-30 | -$5.44M 10-Q · filed 2015-11-05 | -$18.29M 10-Q · filed 2015-11-05 | ||
| 2015-03-31 | -$402.00K 10-Q · filed 2016-05-13 | -$7.11M derived: sum of 2 quarters · filed 2016-05-13 | -$20.44M derived: sum of 3 quarters · filed 2016-05-13 | |
| 2014-12-31 | -$6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$20.04M derived: sum of 2 quarters · filed 2016-03-28 | -$36.74M 10-K · filed 2016-03-28 | |
| 2014-09-30 | -$13.33M 10-Q · filed 2015-11-05 | -$30.03M 10-Q · filed 2015-11-05 | ||
| 2013-12-31 | -$39.61M 10-K · filed 2016-03-28 |